Placebo-Controlled, Ascending, Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs BMS 779788 (Primary)
- Indications Hyperlipidaemia
- Focus Adverse reactions; Biomarker
- 24 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.